GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » Cyclically Adjusted Revenue per Share

Syngene International (BOM:539268) Cyclically Adjusted Revenue per Share : ₹59.55 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Syngene International's adjusted revenue per share for the three months ended in Mar. 2024 was ₹22.849. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹59.55 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Syngene International's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-04-28), Syngene International's current stock price is ₹698.25. Syngene International's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹59.55. Syngene International's Cyclically Adjusted PS Ratio of today is 11.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Syngene International was 15.00. The lowest was 11.01. And the median was 12.76.


Syngene International Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Syngene International's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Cyclically Adjusted Revenue per Share Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 54.01 59.55

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.01 55.97 57.34 58.71 59.55

Competitive Comparison of Syngene International's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Syngene International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Syngene International's Cyclically Adjusted PS Ratio falls into.



Syngene International Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngene International's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=22.849/153.2548*153.2548
=22.849

Current CPI (Mar. 2024) = 153.2548.

Syngene International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.000 91.425 0.000
201409 5.095 96.780 8.068
201412 5.570 96.780 8.820
201503 6.167 97.163 9.727
201506 5.781 99.841 8.874
201509 6.469 101.753 9.743
201512 6.970 102.901 10.381
201603 8.392 102.518 12.545
201606 6.954 105.961 10.058
201609 7.646 105.961 11.059
201612 8.182 105.196 11.920
201703 7.338 105.196 10.690
201706 7.348 107.109 10.514
201709 8.434 109.021 11.856
201712 9.763 109.404 13.676
201803 10.288 109.786 14.361
201806 10.181 111.317 14.017
201809 10.532 115.142 14.018
201812 11.758 115.142 15.650
201903 10.659 118.202 13.820
201906 10.613 120.880 13.455
201909 11.678 123.175 14.530
201912 13.062 126.235 15.858
202003 11.939 124.705 14.672
202006 10.613 127.000 12.807
202009 12.975 130.118 15.282
202012 14.584 130.889 17.076
202103 14.043 131.771 16.333
202106 14.536 134.084 16.614
202109 14.912 135.847 16.823
202112 15.727 138.161 17.445
202203 17.030 138.822 18.801
202206 15.960 142.347 17.183
202209 19.052 144.661 20.184
202212 19.415 145.763 20.413
202303 24.841 146.865 25.922
202306 20.073 150.280 20.470
202309 22.655 151.492 22.919
202312 21.204 153.255 21.204
202403 22.849 153.255 22.849

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Syngene International  (BOM:539268) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Syngene International's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=698.25/59.55
=11.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Syngene International was 15.00. The lowest was 11.01. And the median was 12.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Syngene International Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Syngene International's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (BOM:539268) Business Description

Industry
Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines